Skip to content
10-Q

Quarterly Report

Caribou Biosciences, Inc. CRBU

0001619856-25-000071

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 3, 2025 93.47M sh
Shares Diluted Q3 2025 · Sep 30, 2025 93.29M sh
Shares Diluted Q3 2025 · Sep 30, 2025 93M sh
Shares Diluted Q3 2025 · Sep 30, 2024 90.46M sh
Shares Diluted Q3 2025 · Sep 30, 2024 90.03M sh
Capex Q3 2025 · Sep 30, 2025 $1.58M
Capex Q3 2025 · Sep 30, 2024 $4.36M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$90.17M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$102.73M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $11.14M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $16.29M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $31.97M
Stockholders Equity Q3 2025 · Sep 30, 2025 $141.85M
Stockholders Equity Q3 2025 · Jun 30, 2025 $166.13M
Stockholders Equity Q3 2025 · Mar 31, 2025 $217.22M
Stockholders Equity Q3 2025 · Dec 31, 2024 $252.95M
Stockholders Equity Q3 2025 · Sep 30, 2024 $281.2M
Stockholders Equity Q3 2025 · Jun 30, 2024 $310.46M
Stockholders Equity Q3 2025 · Mar 31, 2024 $343.29M
Stockholders Equity Q3 2025 · Dec 31, 2023 $368.4M
Current Liabilities Q3 2025 · Sep 30, 2025 $28.06M
Current Liabilities Q3 2025 · Dec 31, 2024 $30.65M
Total Liabilities Q3 2025 · Sep 30, 2025 $53.14M
Total Liabilities Q3 2025 · Dec 31, 2024 $60.36M
Current Assets Q3 2025 · Sep 30, 2025 $155.51M
Current Assets Q3 2025 · Dec 31, 2024 $219.38M
Total Assets Q3 2025 · Sep 30, 2025 $194.98M
Total Assets Q3 2025 · Dec 31, 2024 $313.31M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.30
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.31
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.38
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.26
Eps Basic Q3 2025 · Sep 30, 2025 −$0.30
Eps Basic Q3 2025 · Sep 30, 2025 −$1.31
Eps Basic Q3 2025 · Sep 30, 2024 −$0.38
Eps Basic Q3 2025 · Sep 30, 2024 −$1.26
Sga Expense Q3 2025 · Sep 30, 2025 $9.2M
Sga Expense Q3 2025 · Sep 30, 2025 $29.34M
Sga Expense Q3 2025 · Sep 30, 2024 $9.84M
Sga Expense Q3 2025 · Sep 30, 2024 $35.97M
Rd Expense Q3 2025 · Sep 30, 2025 $22.4M
Rd Expense Q3 2025 · Sep 30, 2025 $85.62M
Rd Expense Q3 2025 · Sep 30, 2024 $30.42M
Rd Expense Q3 2025 · Sep 30, 2024 $99.69M
Net Income Q3 2025 · Sep 30, 2025 −$27.55M
Net Income Q3 2025 · Sep 30, 2025 −$121.64M
Net Income Q3 2025 · Jun 30, 2025 −$54.1M
Net Income Q3 2025 · Mar 31, 2025 −$39.99M
Net Income Q3 2025 · Sep 30, 2024 −$34.68M
Net Income Q3 2025 · Sep 30, 2024 −$113.62M
Net Income Q3 2025 · Jun 30, 2024 −$37.7M
Net Income Q3 2025 · Mar 31, 2024 −$41.23M
Operating Income Q3 2025 · Sep 30, 2025 −$29.4M
Operating Income Q3 2025 · Sep 30, 2025 −$119.89M
Operating Income Q3 2025 · Sep 30, 2024 −$38.24M
Operating Income Q3 2025 · Sep 30, 2024 −$127.74M
Revenue Q3 2025 · Sep 30, 2025 $2.2M
Revenue Q3 2025 · Sep 30, 2025 $7.22M
Revenue Q3 2025 · Sep 30, 2024 $2.02M
Revenue Q3 2025 · Sep 30, 2024 $7.92M